Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
22.07
-0.05 (-0.23%)
At close: Jun 24, 2025, 4:00 PM
22.10
+0.03 (0.14%)
After-hours: Jun 24, 2025, 7:47 PM EDT

Catalyst Pharmaceuticals Market Cap

Catalyst Pharmaceuticals has a market cap or net worth of $2.69 billion as of June 24, 2025. Its market cap has increased by 39.73% in one year.

Market Cap
2.69B
Enterprise Value
2.11B
1-Year Change
39.73%
Ranking
Category
Stock Price
$22.07

Market Cap Chart

Since December 15, 2006, Catalyst Pharmaceuticals's market cap has increased from $69.00M to $2.69B, an increase of 3,801.44%. That is a compound annual growth rate of 21.86%.

History

DateMarket Cap% Change
Jun 23, 20252.70B8.39%
Dec 31, 20242.49B38.90%
Dec 29, 20231.79B-7.42%
Dec 30, 20221.94B177.28%
Dec 31, 2021698.10M101.65%
Dec 31, 2020346.20M-10.40%
Dec 31, 2019386.40M95.84%
Dec 31, 2018197.30M-40.80%
Dec 29, 2017333.30M283.10%
Dec 30, 201687.00M-57.12%
Dec 31, 2015202.90M-1.17%
Dec 31, 2014205.30M94.41%
Dec 31, 2013105.60M599.34%
Dec 31, 201215.10M-52.66%
Dec 30, 201131.90M66.15%
Dec 31, 201019.20M68.42%
Dec 31, 200911.40M-54.94%
Dec 31, 200825.30M-41.44%
Dec 31, 200743.20M-28.60%
Dec 29, 200660.50M-12.32%
View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 684.73B
Johnson & Johnson 360.41B
AbbVie 327.31B
Novo Nordisk 326.28B
UnitedHealth Group 273.97B
Abbott Laboratories 231.38B
Novartis AG 227.54B
AstraZeneca 217.06B
Market Cap Rankings